I'll write the friggin release.
''BTA is pleased to advise that GSK has indicated it is increasing its Production capacity to 190 million packs.
The plans include a commitment by GSK to increase its annual production capacity of the influenza anti-viral Relenza to 190 million courses by the end of 2009. This increase represents a threefold increase to GSK�fs previous increased capacity of 60 million courses.
'Going forward BTA looks forward to an increased revenue stream due to this increased production.'' said a delighted Peter Cook.
GSK has confirmed to BTA that they have solid orders received that supports this increased production.""
Disclaimer (This is make beleive)
- Forums
- ASX - By Stock
- BTA
- bta ann. is coming.
bta ann. is coming., page-16
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries